NCT06245122 2026-04-06A Study of CS23546 in Subjects With Advanced TumorsChipscreen Biosciences, Ltd.Phase 1 Recruiting156 enrolled
NCT07110584 2026-03-05Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced TumorsModeX Therapeutics, An OPKO Health CompanyPhase 1/2 Recruiting235 enrolled